Zinc test for early breast cancer looks promising
12/10/2014
Using techniques from the field of earth sciences, researchers may have found a way of picking up early signs of breast cancer by looking for changes in zinc composition.
A yardstick to measure the malignancy of prostate cancer
12/10/2014
A protein that influences the epigenetic characteristics of tumor cells is directly linked to the grade of malignancy of prostate cancer.
Hodgkin lymphoma: Phase 3 AETHERA clinical trial data reported
12/10/2014
Takeda UK Ltd has reported data demonstrating that Hodgkin lymphoma (HL) patients at risk of relapse following an autologous stem cell transplant (ASCT) who received ADCETRIS (brentuximab vedotin)...
Foundation Medicine, Inc. has announced new data demonstrating that its comprehensive genomic profile, FoundationOne® Heme, identified genomic alterations in patients with heavily pre-treated...
Insulin dosage for type 2 diabetes linked with increased death risk
12/10/2014
Analysis of thousands of NHS records has uncovered a link between an increased dosage of insulin in the treatment of type 2 diabetes and a heightened risk of death in patients.
Test assesses whether immune system is holding cancer in check
12/10/2014
Scientists have developed a new high-tech system for measuring the body's immune response to cancer - as a way of assessing how rapidly the disease is likely to progress.
Delayed cancer diagnosis unlikely to be due to poor medical practice
12/10/2014
Poor professional performance is an unlikely cause of delays in referral for suspected cancer, argue researchers in The BMJ this week.
Newly-identified gene mutation could help explain how breast cancer spreads
12/10/2014
A newly-identified genetic mutation could increase our understanding of how breast cancer spreads and potentially guide treatment options for women with the disease, according to a study from...
A phase two study that investigated the potential of the drugs azacitidine (AZA) and lenalidomide (LEN), demonstrated that the two therapies in combination may be an effective frontline treatment...
Young adults with acute lymphoblastic leukemia benefit from therapies developed for children
12/10/2014
Results from a large, prospective clinical trial add to mounting evidence that adolescent and young adult patients--aged 16 to 39 with acute lymphoblastic leukemia (ALL)--tend to fare better when...